(Q41483339)

English

Anticancer drug evaluation: continuing progress from existing methodology

scientific article published on January 1997

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1 October 2017

1 reference

Europe PubMed Central

title

Anticancer drug evaluation: continuing progress from existing methodology (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1 October 2017

ten Bokkel Huinink W

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

publication date

1 January 1997

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

published in

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

volume

33 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

page(s)

S8-10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

cites work

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900447-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900447-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900447-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of survival by tumor response.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900447-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900447-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0959-8049(96)00447-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

PubMed publication ID

9166089

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9166089

retrieved

1 October 2017

(Q41483339)

Anticancer drug evaluation: continuing progress from existing methodology

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)